Influence of Different Doses of Methyl Ethyl Ketone on 2, 5-Hexanedione Concentrations in the Sciatic Nerve. Serum, and Urine of Rats: Takato YASUI et al. Department of Public Health and Hygiene. Oita Medical University-Rats were injected subcutaneously with 2, 5-hexanedione (2, 5 -HD 2.6m mol/kg) alone (HD group) or with 2, 5-HD and methyl ethyl ketone (MEK) (2.6m mol/kg of each agent, HD&MEK group) or with 2, 5-HD 2.6m mol/kg and 5 times that dose (13.0m mol/kg) of MEK (HD&5MEK group). The concentration of 2, 5 -HD in serum and in the sciatic nerve was deter mined 0.5, 1, 2, 4, 8, and 16 h after administration. Urinary 2, 5-HD concentration was determined from the beginning of administration up to 16h after ward. 1) The concentration of 2, 5-HD in the serum, the sciatic nerve, and the urine was increased signi ficantly (p<0.05) in the co-administered groups; the higher the MEK doses were, the greater was the increase. 2) The clearance of 2, 5-HD from both the serum and the sciatic nerve was delayed in the co administered groups. The highest concentration in serum and the sciatic nerve appeared at 1 and 2h respectively. After administration, the biological half life (t1/2) of 2, 5-HD from 1 to 8h in serum was 6.5, 5.8 and 12.0h for the HD, HD&MEK, and HD&5 MEK groups respectively. From 8 to 16h, the t1/2 in serum was 1.2, 3.2 and 16.6h
Introduction
Epidemiological investigations and animal experi ments have shown that hexane and methyl n-butyl ketone (MnBK) cause peripheral polyneuro pathy1-4). The neurotoxicity of hexane and MnBK is thought to be induced ultimately by 2, 5-hexanedione (2, 5-HD), the major metabolite of hexane and MnBK5-9). Several studies have shown that the neurotoxicity of hexane and MnBK was enhanced by co-administration with methyl ethyl ketone (MEK), one mechanism proposed for this enhancement being that MEK could influence the metabolism of hexane and MnBK, especially the metabolism of 2, 5-HD6,10-12) When rats inhaled hexane and MEK, the concentration of 2, 5-HD in the serum and urine and, the area under the serum concentration versus time curve (AUC) decreased13-16) or increased6) in different studies. When the rats were pretreated with MEK orally and then treated with hexane by inhalation, the concentration of 2, 5-HD in the serum, sciatic nerves and testis increased relative to that in sham treated controls 17). Further, the concomitant oral administration of 2, 5-HD and MEK has been shown to reduce serum 2, 5-HD clearance and to in crease the concentration and AUC in serum18). '22) . The biological half-life (t1/2) of 2, 5-HD was calculated according to the formula t1/2=0.693/k24).
Results
Concentration of 2, 5-HD in serum and nerve: Changes in the 2, 5-HD concentration in serum are shown in Fig. 1 . From 1 to 16h after administra tion, the 2, 5-HD concentration in serum increased in the order HD<HD&MEK<HD&5MEK (p< 0.001). For the different times, the concentration increased in the order 16h<8h<4h<2h<0.5h< 1h in the three groups (p<0.001). The most sig nificant difference among the three groups was found at 16h, the mean concentration of 2, 5-HD at this time being 2.4, 26.0, and 165.5mg/I for the HD, HD&MEK, and HD&5MEK groups, respec tively. As shown in Fig. 1 , the 2, 5-HD concentra tion versus time curves were two phase curves (from 1 to 16h), so two of the t1/2 values for each phase (1 to 8h and 8 to 16h) were estimated. From 1 to 8h, the half-life for the HD, HD&MEK, and HD&5MEK groups was 6.5, 5.8 and 12.0h re spectively; from 8 to 16h, the t1/2 for the HD, HD&MEK, and HD&5MEK groups was 1.2, 3.2, and 16.7h, respectively. These results showed that 2, 5-HD clearance from serum was prolonged in the 2, 5-HD and MEK co-administered groups; more over, the higher the MEK dose. and the longer the experiment period, the greater was the prolonga tion.
With regard to nerve tissue, the time course of the concentrations of 2, 5-HD in the sciatic nerve is shown in Fig. 2 . The order of 2, 5-HD concentra tion in the three groups was the same as that of serum, namely, HD<HD&MEK<HD&5MEK
(p <0.001). The mean concentration of 2, 5-HD at different times decreased in the order 16h<8h<4 h<0.5h<lh<2h (p<0.001). The highest con centration in the nerve appeared about 1h later than the highest concentration in serum. On esti mation of 2, 5-HD t1/2, the 2, 5-HD clearance from the nerve was also found to be delayed in the co Concentration of 2, 5-HD in urine and its relation ship with some parameters: Table 1 shows the uri nary 2, 5-HD concentration (UC), urinary 2, 5-HD amount (UA), the AUC of serum and nerve (SAUC and NAUC), and the UA/AD (AD for ad ministration dose) ratios. The urinary 2, 5-HD con centration in the HD&5MEK group was significant ly greater than that of the HD and the HD&MEK groups (p<0.05). The values for 2, 5-HD concen tration in urine, the urinary 2, 5-HD amount, and the UA/AD in the HD&5MEK group were about twice those of the 2, 5-HD alone group (p=0.0597), but, there was no significant difference between the HD and HD&MEK groups.
Ratio of 2, 5-HD concentration in serum/2, 5-HD concentration in the sciatic nerve: The ratios for the 2, 5-HD concentration in serum divided by the 2, 5-HD concentration in the sciatic nerve were de termined. The mean ratios for the three groups (0.5 to 8h) were not significantly different. At 16 h, the sciatic nerve concentration in the HD group was less than the detectable value, so the ratio could not be calculated (Table 2 ).
Discussion
Ralston et al.18) treated rats orally with 2.2mmole /kg 2, 5-HD alone and with equimolecular MEK once a day for 7 days. They found that the clear ance of 2, 5-HD in the co-administered groups was delayed, and that the 2, 5-HD concentration (from 2 to 9h) in the co-administered groups was signifi cantly greater than that in the groups receiving 2, 5 -HD alone. In the same study, it has also been re ported that the values for the AUC in co administered groups were 1.6-1.8 times those for the 2, 5-HD alone groups18). In the present experi ment, in which rats were injected subcutaneously with 2, 5-HD 2.6mmol/kg alone or with this dose combined with an equal dose or 5 times the dose (13.0mmol/kg) of MEK, both the value for the 2, 5-HD concentration of 2, 5-HD and the AUC in the co-administered groups were significantly great er than that in the 2, 5-HD alone group ( Fig. 1 and Table 1 ). Further, the higher the dose of MEK, the stronger was the capture effect of MEK, but when hexane instead of 2, 5-HD was co administered with MEK (co-inhalation or co administration by gavaging), the 2, 5-HD concentra tions in the serum were both increased6,17) or decreased13,16) Values for 2, 5-HD t1/2 in serum, especially when the 2, 5-HD was co-administered with MEK, have merely been reported. The values for t1/2 that we approximated from the values given by Ralston et aL18) were 3.5 and 10.0 for 2, 5-HD alone or for the 2, 5-HD plus MEK group, respectively. That is, the co-administration of 2, 5-HD with MEK prolonged 2, 5-HD tt/2 in the serum, similar to ours in the pre sent series of experiments. Moreover, in the present series of experiments, the difference between the t1/2 of the HD and HD&MEK groups in the early period (1 to 8h) was not significant, whereas in the same 1 to 8h period, when the MEK dose was in creased to 5 times the 2, 5-HD dose (13.0mmol/ kg), the t1/2 of the HD&5MEK group was 1.9 fold that of the HD group. In the 8 to 16h period, the t1/2 of the HD&MEK and HD&5MEK groups was 2.8 and 13 times, respectively, that of the 2, 5 -HD alone group. These results suggest that the t1/2 is prolonged more significantly during the later period and also when 2, 5-HD is co-administered with a greater dose of MEK. It has been reported that MEK administered orally prior to hexane inhalation increases the 2, 5 -HD concentration in the sciatic nerve17). In the present series of experiments, the 2, 5-HD concen tration in the sciatic nerve was significantly in creased in the co-administered groups. Moreover, we also found that the clearance of 2, 5-HD from the nerve was delayed in the co-administered groups. It should be noted that in the 2 to 8h period, the 2, 5-HD t1/2 in the nerve tissue in the HD& MEK and HD&5MEK groups was 1.9 and 3.9 times that in the HD group (9.6/5.2, 19.9/5.2), whereas in the serum these values were only 1.0 (5.9/5.8) for the HD&MEK/HD groups and 1.9 (10.0/5.8) for the HD&5MEK/HD groups. These findings suggest that MEK delayed the clearance of 2, 5-HD in the nerve tissue to a greater extent than that in the serum. A good correlation (r=0.86, p<0.001) between the concentration in the sciatic nerve and serum was found in this series of experiments. This corre lation was not changed in the groups receiving co administration with MEK. Furthermore, the ratio of the 2, 5-HD concentration in the serum/2, 5-HD concentration in the nerve did not differ significantly among the three groups. Thus it is possible to esti mate the 2, 5-HD concentration in nerve from the serum concentration, but reported values for the ratio of the 2, 5-HD concentration in the serum to the 2, 5-HD concentrations in the nerve vary in different studies. We estimated that this ratio was about 1.0 in both their hexane and hexane plus MEK pre treatment groups from the reported results of Rob ertson et al. 17) . From the data published by Ralston18) et al. and Suwita20) et al., we calculated that the ratios for serum/nerve radioactivity were 0.8 to 1.7 for the 2, 5-HD alone group and 0.8 to 2.3 for the co-administered group. As the radioac tivity in the Ralston18) et al. and Suwita et al. studi es could reflect that of compounds other than 2, 5-HD, it is difficult to compare our results with the data estimated from these two studies. Further more, the administration procedure plays a role. Suwita et al.20) reported that only 1.2% of the 2, 5 -HD administered to hens on the skin (50mg/kg) was eliminated in urine within 24h. In the present study, we found that 1.5%, 1.6%, and 3.1% of the 2, 5-HD administered was eliminated within 16h in the HD, HD&MEK and HD&5MEK groups, re spectively (p=0.059). The amount of 2, 5-HD eli minated in the urine of the HD&5MEK group was two times that of the 2, 5-HD alone group (Table  1) . These results showed that 2, 5-HD elimination in urine was increased when the agent was co administered with 5 times the dose of MEK. Where as, when it was inhaled with hexane and MEK, 2, 5-HD elimination was decreased [13] [14] [15] . The uri nary concentration correlated well with the serum concentration (r=0.81, p<0.01) and nerve concen tration (r=0.80, p<0.01) in the present experi ment, indicating that the increase in the urine 2, 5 -HD concentration in the HD&5MEK group paral leled the increase in serum 2, 5-HD concentration in that group. In the present series of experiments, it should be noticed that the time change course of the 2, 5-HD concentration in the serum and nerve appeared as a non-linear curve on the semi-logarithm graph ( Figs.  1 and 2) . That is the t1/2 was prolonged when the 2, 5-HD concentration in serum or nerve was higher than a certain level. This model is thought to pre dominantly reflect the limitation of liver metabolic capacity23,26,27) in relation to the amount of agents that have being metabolized in liver. According to this explanation, it could be hypothesized that if the total dose of 2, 5-HD and MEK is too great to be metabolized in the liver (even if the 2, 5-HD amount is relatively small, the 2, 5-HD concentration in the serum and nerve could be increased. In the present series of experiments, the clearance of 2, 5-HD was prolonged to a greater extent in the nerve than that in serum), and this fact was thought to be related to the neurotoxicity enhancement of 2, 5-HD caused by MEK, but the mechanism whereby MEK pro longs 2, 5-HD t1/2 in the nerve should be further in vestigated. 
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